Harvard Bioscience Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| WEBER CAPITAL MANAGEMENT LLC /ADV | 08/13/2026 | 310.86 K | $1.91 M | -2.87% | 6.87% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 179.61 K | $1.10 M | 0.00% | 3.97% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 169.63 K | $1.04 M | 3.87% | 3.75% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 122.81 K | $755.28 K | -1.60% | 2.71% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 114.55 K | $704.45 K | 0.38% | 2.53% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 99.33 K | $610.86 K | -2.07% | 2.19% |
| BLACKROCK, INC. | 08/07/2026 | 61.83 K | $380.28 K | -0.63% | 1.37% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 47.56 K | $292.53 K | -20.09% | 1.05% |
| MINK BROOK ASSET MANAGEMENT LLC | 08/14/2026 | 33.37 K | $205.22 K | 100.00% | 0.74% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 32.62 K | $200.61 K | -29.60% | 0.72% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 27.73 K | $170.54 K | 0.00% | 0.61% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 08/06/2026 | 26.97 K | $165.88 K | -0.18% | 0.60% |
| WILLIAMS & NOVAK, LLC | 07/08/2026 | 20.95 K | $128.84 K | -22.56% | 0.46% |
| UBS GROUP AG | 08/13/2026 | 17.58 K | $108.12 K | 109.17% | 0.39% |
| RBF CAPITAL, LLC | 08/14/2026 | 16.00 K | $98.40 K | 0.00% | 0.35% |
| STATE STREET CORP | 09/22/2026 | 14.93 K | $91.83 K | 0.00% | 0.33% |
| JANE STREET GROUP, LLC | 08/14/2026 | 13.98 K | $85.99 K | -41.33% | 0.31% |
| CITADEL ADVISORS LLC | 09/02/2026 | 13.25 K | $81.49 K | 100.00% | 0.29% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 10.66 K | $65.54 K | 100.00% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 10.23 K | $62.92 K | 0.00% | 0.23% |
| FMR LLC | 08/13/2026 | 3.18 K | $19.55 K | -2.90% | 0.07% |
| MORGAN STANLEY | 08/13/2026 | 1.63 K | $10.01 K | -0.06% | 0.04% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 1.22 K | $7.51 K | 0.00% | 0.03% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 866 | $5.33 K | 0.00% | 0.02% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 580 | $3.57 K | -49.65% | 0.01% |
| BROWN SHIPLEY& CO LTD | 07/14/2026 | 478 | $2.94 K | 0.00% | 0.01% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 240 | $1.48 K | -89.00% | 0.01% |
| NISA INVESTMENT ADVISORS, LLC | 08/10/2026 | 228 | $1.40 K | 0.00% | 0.01% |
| PENSION & WEALTH MANAGEMENT ADVISORS, INC. | 08/07/2026 | 225 | $1.38 K | 0.00% | 0.01% |
| JPMORGAN CHASE & CO | 08/12/2026 | 195 | $1.19 K | -95.63% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 66 | $406 | -2.94% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 26 | $160 | 100.00% | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 08/07/2026 | 14 | $86 | 0.00% | 0.00% |
| SHP WEALTH MANAGEMENT | 08/11/2026 | 10 | $62 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| FEDERATED HERMES, INC. | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
Harvard Bioscience Inc. institutional Ownership - FAQ's
During the previous two years, 72 institutional investors and hedge funds held shares of Harvard Bioscience Inc.. The most heavily invested institutionals were:
WEBER CAPITAL MANAGEMENT LLC /ADV: 310,861
ACADIAN ASSET MANAGEMENT LLC: 179,614
VANGUARD CAPITAL MANAGEMENT LLC: 169,625
CORSAIR CAPITAL MANAGEMENT, L.P.: 122,810
TWO SIGMA INVESTMENTS, LP: 114,545
RENAISSANCE TECHNOLOGIES LLC: 99,327
29.90% of Harvard Bioscience Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16.02 M shares in the last 24 months. This purchase volume represents approximately $7.85 M in transactions.